Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEY (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis".